RIGEL PHARMACEUTICALS INC — Director's Dealing 2017

Dec 23, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2017-12-18

Reporting Person: Cabatuan Nelson (Principal Accounting Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	58	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$6.48	2018-11-13	Common Stock (1212)		Direct
Stock Option (Right to Buy)	$6.49	2019-03-30	Common Stock (3250)		Direct
Stock Option (Right to Buy)	$6.73	2021-02-01	Common Stock (5000)		Direct
Stock Option (right to Buy)	$6.73	2021-02-01	Common Stock (5000)		Direct
Stock Option (Right to Buy)	$8.15	2022-01-25	Common Stock (10000)		Direct
Stock Option (Right to Buy)	$6.51	2023-01-30	Common Stock (2500)		Direct
Stock Option (Right to Buy)	$3.55	2023-09-19	Common Stock (6000)		Direct
Stock Option (Right to Buy)	$3.2	2024-01-29	Common Stock (10000)		Direct
Stock Option (Right to Buy)	$3.2	2024-01-29	Common Stock (6500)		Direct
Stock Option (Right to Buy)	$1.68	2024-11-12	Common Stock (10834)		Direct
Stock Option (Right to Buy)	$2.14	2025-01-26	Common Stock (15500)		Direct
Stock Option (Right to Buy)	$2.72	2026-01-22	Common Stock (30000)		Direct
Stock Option (Right to Buy)	$3.67	2026-10-03	Common Stock (30000)		Direct
Stock Option (Right to Buy)	$2.10	2027-01-24	Common Stock (44888)		Direct
Stock Option (Right to Buy)	$2.10	2027-01-24	Common Stock (10000)		Direct
Stock Option (Right to Buy)	$2.10	2027-01-24	Common Stock (112)		Direct

Footnotes

F1: This option is fully vested.

F2: This option vests monthly over four (4) years from January 1, 2014.

F3: This option vests monthly over four (4) years from October 1, 2014.

F4: This option vests monthly over two (2) years from January 1, 2016.

F5: This option vests monthly over four (4) years from October 3, 2016.

F6: This option vests monthly over four (4) years from January 1, 2017.